This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Summary: In this issue of Cancer Discovery, Clarke and colleagues define the genetic landscape of infantile cerebral high-grade gliomas, which frequently contain alterations in the MAPK pathway, as well as recurrent gene fusions in receptor tyrosine kinases (ALK, ROS1, MET) and neurotrophic receptor kinases (NTRK1–3). Combining their multi-omic profiling data with functional preclinical and clinical studies, this large multi-institutional study provides strong rationale for future classification and molecular subtype–specific therapeutic management of infantile high-grade glioma.
See related article by Clarke et al., p. 942.
Footnotes
Cancer Discov 2020;10:904–6
- ©2020 American Association for Cancer Research.
Log in using your username and password
Purchase access
Volume 10, Issue 7
